APP is a type I single pass transmembrane protein highly expressed in the central nervous system (CNS) which is processed by α-, β-, and γ-secretases (Hardy and Selkoe, 2002) to generate beta amyloid (Aβ) peptide fragments that comprise the amyloid plaques found in Alzheimer’s disease (AD) patients post-mortem. Here, APP is linked to Alzheimer disease.